213 related articles for article (PubMed ID: 1696955)
21. Human CD4+ T cells can discriminate the molecular and structural context of T epitopes of HIV gp120 and HIV p66.
Manca F; Fenoglio D; Valle MT; Li Pira G; Kunkl A; Ferraris A; Saverino D; Lancia F; Mortara L; Lozzi L
J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Jul; 9(3):227-37. PubMed ID: 7540488
[TBL] [Abstract][Full Text] [Related]
22. Persistent infection of MT-4 cells by human immunodeficiency virus type 1 becomes increasingly likely with in vitro serial passage of wild-type but not nef mutant virus.
Nishino Y; Nakaya T; Fujinaga K; Kishi M; Azuma I; Ikuta K
J Gen Virol; 1994 Sep; 75 ( Pt 9)():2241-51. PubMed ID: 7521392
[TBL] [Abstract][Full Text] [Related]
23. Human immunodeficiency virus infection and syncytium formation in HeLa cells expressing glycophospholipid-anchored CD4.
Kost TA; Kessler JA; Patel IR; Gray JG; Overton LK; Carter SG
J Virol; 1991 Jun; 65(6):3276-83. PubMed ID: 1709701
[TBL] [Abstract][Full Text] [Related]
24. Treatment of HIV tissue culture infection with monoclonal antibody-ricin A chain conjugates.
Pincus SH; Wehrly K; Chesebro B
J Immunol; 1989 May; 142(9):3070-5. PubMed ID: 2540236
[TBL] [Abstract][Full Text] [Related]
25. CD4-Pseudomonas exotoxin hybrid protein blocks the spread of human immunodeficiency virus infection in vitro and is active against cells expressing the envelope glycoproteins from diverse primate immunodeficiency retroviruses.
Berger EA; Clouse KA; Chaudhary VK; Chakrabarti S; FitzGerald DJ; Pastan I; Moss B
Proc Natl Acad Sci U S A; 1989 Dec; 86(23):9539-43. PubMed ID: 2480605
[TBL] [Abstract][Full Text] [Related]
26. Use of a focal infectivity assay for testing susceptibility of HIV to antiviral agents.
Pincus SH; Wehrly K; Chesebro B
Biotechniques; 1991 Mar; 10(3):336-42. PubMed ID: 2064772
[TBL] [Abstract][Full Text] [Related]
27. Conserved molecular signatures in gp120 are associated with the genetic bottleneck during simian immunodeficiency virus (SIV), SIV-human immunodeficiency virus (SHIV), and HIV type 1 (HIV-1) transmission.
Gonzalez MW; DeVico AL; Lewis GK; Spouge JL
J Virol; 2015 Apr; 89(7):3619-29. PubMed ID: 25589663
[TBL] [Abstract][Full Text] [Related]
28. The N-terminal region of the human immunodeficiency virus envelope glycoprotein gp120 contains potential binding sites for CD4.
Syu WJ; Huang JH; Essex M; Lee TH
Proc Natl Acad Sci U S A; 1990 May; 87(10):3695-9. PubMed ID: 2339113
[TBL] [Abstract][Full Text] [Related]
29. V2 loop glycosylation of the human immunodeficiency virus type 1 SF162 envelope facilitates interaction of this protein with CD4 and CCR5 receptors and protects the virus from neutralization by anti-V3 loop and anti-CD4 binding site antibodies.
Ly A; Stamatatos L
J Virol; 2000 Aug; 74(15):6769-76. PubMed ID: 10888615
[TBL] [Abstract][Full Text] [Related]
30. Priming of CD4+ T cells specific for conserved regions of human immunodeficiency virus glycoprotein gp120 in humans immunized with a recombinant envelope protein.
Abrignani S; Montagna D; Jeannet M; Wintsch J; Haigwood NL; Shuster JR; Steimer KS; Cruchaud A; Staehelin T
Proc Natl Acad Sci U S A; 1990 Aug; 87(16):6136-40. PubMed ID: 1696717
[TBL] [Abstract][Full Text] [Related]
31. Identification of human immunodeficiency virus envelope gene sequences influencing viral entry into CD4-positive HeLa cells, T-leukemia cells, and macrophages.
Chesebro B; Nishio J; Perryman S; Cann A; O'Brien W; Chen IS; Wehrly K
J Virol; 1991 Nov; 65(11):5782-9. PubMed ID: 1920616
[TBL] [Abstract][Full Text] [Related]
32. Intracellular distribution of the envelope glycoprotein of human immunodeficiency virus and its role in the production of cytopathic effect in CD4+ and CD4- human cell lines.
Koga Y; Sasaki M; Nakamura K; Kimura G; Nomoto K
J Virol; 1990 Oct; 64(10):4661-71. PubMed ID: 2204721
[TBL] [Abstract][Full Text] [Related]
33. Identification of Human Anti-HIV gp160 Monoclonal Antibodies That Make Effective Immunotoxins.
Pincus SH; Song K; Maresh GA; Hamer DH; Dimitrov DS; Chen W; Zhang MY; Ghetie VF; Chan-Hui PY; Robinson JE; Vitetta ES
J Virol; 2017 Feb; 91(3):. PubMed ID: 27852851
[TBL] [Abstract][Full Text] [Related]
34. Longitudinal analysis of T cell receptor (TCR) gene usage by human immunodeficiency virus 1 envelope-specific cytotoxic T lymphocyte clones reveals a limited TCR repertoire.
Kalams SA; Johnson RP; Trocha AK; Dynan MJ; Ngo HS; D'Aquila RT; Kurnick JT; Walker BD
J Exp Med; 1994 Apr; 179(4):1261-71. PubMed ID: 8145043
[TBL] [Abstract][Full Text] [Related]
35. Comparative clonal analysis of human immunodeficiency virus type 1 (HIV-1)-specific CD4+ and CD8+ cytolytic T lymphocytes isolated from seronegative humans immunized with candidate HIV-1 vaccines.
Hammond SA; Bollinger RC; Stanhope PE; Quinn TC; Schwartz D; Clements ML; Siliciano RF
J Exp Med; 1992 Dec; 176(6):1531-42. PubMed ID: 1460417
[TBL] [Abstract][Full Text] [Related]
36. Interaction with CD4 and antibodies to CD4-induced epitopes of the envelope gp120 from a microglial cell-adapted human immunodeficiency virus type 1 isolate.
Martín-García J; Cocklin S; Chaiken IM; González-Scarano F
J Virol; 2005 Jun; 79(11):6703-13. PubMed ID: 15890908
[TBL] [Abstract][Full Text] [Related]
37. HIV envelope glycoprotein-induced cell killing by apoptosis is enhanced with increased expression of CD26 in CD4+ T cells.
Jacotot E; Callebaut C; Blanco J; Rivière Y; Krust B; Hovanessian AG
Virology; 1996 Sep; 223(2):318-30. PubMed ID: 8806567
[TBL] [Abstract][Full Text] [Related]
38. Characterization of siamycin I, a human immunodeficiency virus fusion inhibitor.
Lin PF; Samanta H; Bechtold CM; Deminie CA; Patick AK; Alam M; Riccardi K; Rose RE; White RJ; Colonno RJ
Antimicrob Agents Chemother; 1996 Jan; 40(1):133-8. PubMed ID: 8787894
[TBL] [Abstract][Full Text] [Related]
39. Neutralizing antibodies directed against the V3 loop select for different escape variants in a virus with mutated reverse transcriptase (M184V) than in wild-type human immunodeficiency virus type 1.
Inouye P; Cherry E; Hsu M; Zolla-Pazner S; Wainberg MA
AIDS Res Hum Retroviruses; 1998 Jun; 14(9):735-40. PubMed ID: 9643373
[TBL] [Abstract][Full Text] [Related]
40. Differences in the antibody response to human immunodeficiency virus-1 envelope glycoprotein (gp160) in infected laboratory workers and vaccinees.
Pincus SH; Messer KG; Schwartz DH; Lewis GK; Graham BS; Blattner WA; Fisher G
J Clin Invest; 1993 May; 91(5):1987-96. PubMed ID: 7683694
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
